Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-08-22
2010-06-01
Shiao, Rei-tsang (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S336000, C546S268100, C548S953000, C548S530000
Reexamination Certificate
active
07727978
ABSTRACT:
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-Beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure:enantiomers, diastereomers, solvates, or salts thereof, wherein A, W, X and Z are defined herein.
REFERENCES:
patent: 3083204 (1963-03-01), Klavehn et al.
patent: 4691051 (1987-09-01), Georgiev et al.
patent: 6242615 (2001-06-01), Pelleter et al.
patent: 6740647 (2004-05-01), Baucke et al.
patent: 2003/0114460 (2003-06-01), Hughes et al.
patent: 2004/0072830 (2004-04-01), Okada et al.
patent: 2004/0209858 (2004-10-01), Bennani et al.
patent: 2005/0070720 (2005-03-01), Balkovec et al.
patent: 2005/0277647 (2005-12-01), Link et al.
patent: 2006/0079506 (2006-04-01), Linders et al.
patent: 2006/0094699 (2006-05-01), Kampen et al.
patent: 2006/0111348 (2006-05-01), Kampen et al.
patent: 2006/0111366 (2006-05-01), Andersen et al.
patent: 2006/0148871 (2006-07-01), Rohde et al.
patent: 2006/0149070 (2006-07-01), Rohde et al.
patent: 2009/0124609 (2009-05-01), Albrecht et al.
patent: 2009/0124612 (2009-05-01), Albrecht et al.
patent: 0130882 (1985-01-01), None
patent: 0699438 (1996-03-01), None
patent: 2002-356458 (2002-12-01), None
patent: WO 92/18132 (1992-10-01), None
patent: WO 95/09634 (1995-04-01), None
patent: WO 97/33859 (1997-09-01), None
patent: WO 98/05336 (1998-02-01), None
patent: WO 98/25923 (1998-06-01), None
patent: WO 98/43946 (1998-10-01), None
patent: WO 99/09984 (1999-03-01), None
patent: WO 99/31075 (1999-06-01), None
patent: WO 99/37668 (1999-07-01), None
patent: WO 01/60818 (2001-08-01), None
patent: WO 02/076973 (2002-10-01), None
patent: WO 03/063845 (2003-08-01), None
patent: WO 03/065983 (2003-08-01), None
patent: WO 2004/056745 (2004-07-01), None
patent: WO 2004/065351 (2004-08-01), None
patent: WO 2004/089415 (2004-10-01), None
patent: WO 2004/089416 (2004-10-01), None
patent: WO 2004/089470 (2004-10-01), None
patent: WO 2004/089896 (2004-10-01), None
patent: WO 2006/069787 (2006-07-01), None
patent: WO 2006/074244 (2006-07-01), None
patent: WO 2007/038452 (2007-04-01), None
patent: WO 2007/047625 (2007-04-01), None
patent: WO 2007/068330 (2007-06-01), None
Kampen et al., 2004, CAS: 141: 360694.
Mao et al., 2004, CAS: 141: 207043.
Balkovec et al., 2003, CAS: 139: 180065.
Dooley et al., 2003, CAS: 139: 164792.
Georgiev et al., 1988, CAS: 108: 6426.
Fleming et al., 1982, CAS: 97: 109824.
Baiocchi et al., 1974, CAS: 81: 25277.
Zoidis et al., 2005, CAS: 142: 481759.
Bhattacharyya, K.C., Current Science, No. 11, pp. 312-313 (1952).
Robl Jeffrey A.
Ye Xiang-Yang
Bogie Terence J.
Bristol--Myers Squibb Company
Shiao Rei-tsang
LandOfFree
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4244960